Correction: Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
Main text
Bak RO, Dever DP, Reinisch A, Hernandez DC, Majeti R, Porteus MH. 2017. Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6. eLife 6:e27873. doi: 10.7554/eLife.27873.
Published 28, September 2017
In the Material and Methods section of our originally published manuscript, we erroneously defined the concentration of the small molecule StemRegenin 1, (SR1) used for hematopoietic stem and progenitor cell culture, as 0.75mM. The correct concentration for SR1 should be 0.75µM instead of 0.75mM.
The article has been corrected accordingly.
Article and author information
Author details
Version history
Copyright
© 2018, Bak et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 618
- views
-
- 2
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Correction: Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
eLife 7:e43690.
https://doi.org/10.7554/eLife.43690
